KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Average Pmpm By Product TypeAverage Pmpm Fees / Revenue Per Case By SegmentAverage Unique MembersAverage Unique Members AnnualAverage Yield Per CaseBreakdown Of AssetsContractual ObligationsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionLives By Product TypeLives Managed By SegmentLives On Platform/ Cases During Period By SegmentNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty And Equipment, NetRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By End MarketRevenue By End Market %Revenue By End Market AnnualRevenue By End Market Annual %Revenue By Product TypeRevenue By Product Type %Revenue By Product Type AnnualRevenue By Product Type Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Cases ManagedTotal Lives ManagedTotal Lives On Platform
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolent Health (EVH) Gross Profit (2023 - 2025)

Evolent Health has reported Gross Profit over the past 11 years, most recently at $97.3 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 28.45% year-over-year to $97.3 million; the TTM value through Dec 2025 reached $399.9 million, up 8.86%, while the annual FY2025 figure was $399.9 million, 8.86% up from the prior year.
  • Gross Profit for Q4 2025 was $97.3 million at Evolent Health, down from $99.8 million in the prior quarter.
  • Over five years, Gross Profit peaked at $124.4 million in Q3 2023 and troughed at $49.9 million in Q2 2021.
  • A 5-year average of $89.7 million and a median of $91.6 million in 2022 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: soared 66.87% in 2023 and later plummeted 35.15% in 2024.
  • Year by year, Gross Profit stood at $83.9 million in 2021, then fell by 0.97% to $83.1 million in 2022, then rose by 22.35% to $101.6 million in 2023, then fell by 25.5% to $75.7 million in 2024, then increased by 28.45% to $97.3 million in 2025.
  • Business Quant data shows Gross Profit for EVH at $97.3 million in Q4 2025, $99.8 million in Q3 2025, and $100.4 million in Q2 2025.